On 15 December 2020, the Australian Therapeutic Goods Administration (TGA) published its decision to down-schedule certain low dose...
Cortex - Life Sciences Insights
On December 4, 2020, the United States House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement Act of 2020...
On 25 November 2020, the European Commission published its Pharmaceutical Strategy for Europe (Strategy). The Strategy is relevant for...
On 27 November 2020, the Australian Minister for Health announced an intention to make universal, whole-of-population telehealth services...
As the legal landscape for hemp continues to evolve, manufacturers and sellers of CBD products face increased challenges, such as an...
The COVID-19 pandemic has caused healthcare systems around the globe to rapidly, and in some cases, radically rethink the delivery of...
The Court of Justice of the European Union (CJEU) has ruled that EU Member States cannot prohibit the marketing of cannabidiol (CBD)...
By a slim majority of 50.7% to 48.4%, New Zealanders have voted against the legalisation of recreational cannabis following the...
Hemp production in the US has soared in the last five years and is expected to continue its high rate of production and growth in the...
The UK FSA's announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the...
What are commitments? The recent effort by the Commission to settle the Aspen case suggests that commitment decisions are the preferred...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5a294fe83d947616fca6aa31/2020-10-22-15-57-24-723-5f91abe453548803c8ff38e1.JPG)
This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...
On 17 October 2020, the Standing Committee of the PRC National People’s Congress (“NPC”) passed the PRC Biosecurity Law, which will...
On 19 February 2019, the Narcotics Act (No. 7) B.E. 2562 (2019) came into force ("Narcotics Act"). This decriminalised the use of...
On 18 September the published guidance on the listing of cannabis-based businesses onto public stock exchanges in the UK. We consider the...
